3 results within Condition Category: Nervous System Diseases Remove filter Countries of recruitment: Serbia Remove filter

• ISRCTN21534255 : Comparison of Alemtuzumab and Rebif® Efficacy in Multiple Sclerosis, Study One

  Overall trial status

  Completed

  Recruitment status

  No longer recruiting

  Published

  Serbia

  Nervous System Diseases

  Date assigned

  11/03/2009

• ISRCTN70702834 : Comparison of Alemtuzumab and Rebif® Efficacy in Multiple Sclerosis, Study Two

  Overall trial status

  Completed

  Recruitment status

  No longer recruiting

  Published

  Serbia

  Nervous System Diseases

  Date assigned

  11/03/2009

• ISRCTN55858075 : A randomised, double-blind, placebo-controlled, dose-escalation study of multiple doses of BIIB014 administered orally in subjects with early Parkinson's disease

  Overall trial status

  Completed

  Recruitment status

  No longer recruiting

  Published

  Serbia

  Nervous System Diseases

  Date assigned

  30/08/2007